BREAKTHROUGH CLINICAL STUDY, FIRST OF ITS KIND, PROVES TRAYA CUSTOMIZED REGIMEN DELIVERS 3X* BETTER RESULTS THAN THE MOST PRESCRIBED HAIR GROWTH SERUM

▴ Traya health
~Shattering market myths, this study highlights an efficacious, root-cause-driven solution, setting a new standard for hair loss ~

Key Highlights of the study:

  1. One of a kind study that proves the combined role Ayurveda plays in treating hair loss and backs it with evidence.
  2. The study design was strenuous with a sample set of 135 participants & comparative group of that used 5% topical Minoxidil and was conducted over the span of 6 months.
  3. This study goes beyond conventional comb tests methods used by brands to measure hair fall caused by hair breakage, and includes tools such as Trichoscan® and CaseLite which give an accurate measurement of clinical hair loss.

 

Hyderabad, December 6, 2024: Traya, India's first health-tech brand to treat hair loss internally, announced revolutionary results from a first-of-its-kind study on the efficacy of  Traya Hair loss treatment over Minoxidil in hair loss management. Conducted over six months with 135 male participants aged 18 to 45, the study revealed a landmark finding for hair density: Traya’s Customized Hair Regimen proved to be  thrice as effective than the single use of world's most efficacious molecule Minoxidil, in reducing Male Pattern Hair Loss. This study marks an astounding revelation in the field of hair loss solutions, challenging a widely marketed belief that a single serum can successfully treat hair loss.

 

With a strong emphasis on research-driven, customer-centric solutions, Traya initiated the study in association with MS Clinical Research Pvt Ltd - an independent CRO in Bangalore, to conduct this study. The brand boldly challenged market myths that promise rapid hair loss reversal through the application of single products like oils, shampoos & serums.The brand went a step further and executed the study by directly comparing its customized regimen with Minoxidil.  Participants were divided into three groups: Group A, which used Traya’s Customized Hair Regimen; Group B, which used 5% Minoxidil Topical Solution and Group C, which used placebo (distilled water).

 

The research employed advanced assessment techniques such as Trichoscan® Imaging, Comb Testing, Dermatological Evaluations, and Self-Assessments to ensure the highest reliability in measuring efficacy. Trichoscan Imaging, recognized as the gold standard for clinically determining results in hair loss studies, played a pivotal role in this trial. Traya’s Customized Hair Regimen (Group A) emerged as a clear leader, reducing hair fall thrice  as effectively as Minoxidil alone (Group B).  While brands have relied on comb tests, which often mislead consumers by measuring temporary hair breakage instead of actual follicular hair loss, this six-month clinical trial focused on real hair fall reduction, setting a new industry standard.

 

The study, conducted on 135 participants in line with CTRI (Clinical Trial Registry India) and Ethics committee guidelines, provided highly reliable insights. Participants were equally divided into groups based on common underlying issues like indigestion, acidity, low energy, constipation, bloating, stress, and sleep deprivation, which tend to serve as key root causes of hair loss, ensuring the research addressed a wide range of concerns.

 

Traya’s Customized Hair Regimen combines Ayurveda with Dermatology & a curated diet plan to address specific root causes that lead to hair loss. Traya’s Customized Regimen and serum showed exceptional results, outperforming the Minoxidil serum alone in essential parameters like hair regrowth, hair density, hair fall reduction, smoothness and shine.

Saloni Anand, Co-Founder of Traya, shared, “At Traya, our customers are at the heart of everything we do. We understand that hair loss is deeply personal and can significantly impact one’s confidence and well-being. In fact, for years, doctor prescribed minoxidil has been seen as the go-to solution, which provides superficial relief but falls short in fully tackling the root causes of hair loss. We aimed to challenge the belief that 5%Minoxidil alone can solve the problem, by offering a more result-driven approach. We invested 6 months in this research to test Traya Hair Loss treatment efficacy against Minoxidil alone. The beauty of this test was that we added a consumer group with placebo to negate any biases. The study proved that the Traya 3X approach to hair loss is effective in reversing genetic hair loss and it goes beyond surface-level remedies, addressing the root causes of hair loss through a mix of Ayurveda and modern science

She added, “This study is a testament to our commitment to providing personalized, holistic care that truly makes a difference. By integrating Ayurveda, nutrition, and dermatology, we’re able to deliver results that not only address hair loss but also restore confidence and transform lives. Our mission is to empower people with the knowledge and practices that help them take control of their hair health and feel confident once again.”

For more details on the study, please check:

https://traya.health/pages/mens-clinical-trial


About Traya

Established in 2019, Traya is India’s first-ever hair fall solutions brand to help treat hair fall internally by identifying the root cause of hair fall. With the growing burden of hair fall issues in India, the brand has developed a unique doctor-backed?solution?where customers can take a free hair test that helps them understand the root cause of their hair fall. Traya has built its unique stack of tech, people and formulations that includes its online diagnosis, formulations coming from three sciences, a hair care team of hair coaches and doctors - all together helping them deliver unmatched outcomes for more than 8 Lakh?customers who have chosen Traya. Today the brand has a workforce of about 800 employees and strong brand tie-ups with leading e-commerce brands, Flipkart and Amazon.

Website: https://traya.health/ 

Tags : #traya #trayahealth

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026
Prostate Health Awareness: What Every Indian Man Needs to KnowAugust 07, 2026
Testosterone Levels Explained: Normal Ranges by Age, Causes of Imbalance, and What to DoAugust 07, 2026
“AI can read a chest X-ray in 1.3 seconds” says Dr. Marios Loukas, President and Dean of the School of Medicine, St. George’s UniversityAugust 06, 2026
UK Mental Healthcare Leader Care ADHD To Open Its First Clinic in Bengaluru This October, Bringing NHS-Backed ADHD Care Model to IndiaAugust 06, 2026
Aster DM Quality Care Reports Strong Q1 FY27: Revenue Up 20 Per Cent to Rs 2,597 Cr, Operating EBITDA Up 30 Per CentAugust 06, 2026